Altimmune tanks 38% - end of the road for Nasal Vaccine

Altimmune's devastating clinical results announced yesterday results in a 38% cataclysm. The decision to stop developing the nasal covid vaccine probably means Altimmune should come out of the Index.

VBI also dropped a full 10% even though its data was relatively good.

Vaxart dropped 9% and OncoSec fell 5%.

With these bad results, the overall index registered a loss of 1.8% on average with 17 falling and 10 gaining ground.

On the positive side, CureVac is regaining some its devastating losses from last week, gaining 9%. 

Both PDS and Translate Bio picked up 7%.

 

Modest gains (+0.9%) to start the week

Stocks moved up by 0.9% on average with 17 gaining ground and 10 losing.

The biggest gainer was PDSB which picked up over 6%, while Immunity Bio and Adaptive picked up 5%.

The biggest loser on the day was Alnylam, losing 5%.

 

CureVac back into BOTTOM TEN after tough week

Adaptive is the top performer in the BOTTOM TEN, moving up 16% in its overall return. 

CureVac tumbles into BOTTOM TEN with poor clinical results. 

 

Number 1 is Number 1: Novavax upped its return by 96%. Overall average up from 197% to 210%

Novavax was the strongest stock by far again. The total return for all COVID VACCINE STOCKS have gone above 200% again - up from 197% to 210%.

The biggest stocks are performing the best, Moderna upped its return by 80% and BioNTech was up by 50%. 

After Novavax and Moderna, Translate Bio was the strongest with a gain of 70%, pushing into the TOP TEN, bumping Immunity Bio.  Sorrento was also strong with a gain of 58%.

 

Completely flat outcome to end the week. Onco Sec falls 9% while Tonix falls 8%

The week ended absolutely flat with 17 gaining ground and 10 losing ground.

The biggest loser today was OncoSec which fell over 9%. Vir slipped 8% while Generex fell 6%. 

Tonix lead to the upside with an 8% gain and CureVac picked up 6%.

 

Sorrento picked up almost 11% - on positive day with a gain of 1.3% on average

Solid positive day with 18 stocks gaining ground with only 9 losing ground.

The overall average was a gain of 1.3%.

Today's top performer was Sorrento gained just under 11%.  Vaxart picked up 6%, while CureVac and Vir picked up 5%.

 

NanoViricides picks up 12% - Translate Bio up 9% on fairly strong day

A fairly strong day with an overall average gain of 1.9%. NanoViricides lead the way with a 12% gain. Translate Bio continued recent strength with a 9% gain.

IBio picked up 7% and Gritstone picked up 5%.

There were 18 gainers with nine losing ground.

 

BIG BOYS STRONG. Translate Bio jumps 10%

Twelve stocks gained ground while 14 fell. Still the overall average gain was 0.7% thanks to out-sized gains by several stocks including Translate Bio, Nanoviricides and GeoVax. 

The big vaccine producing stocks were very strong: Novavax gained 7%, Moderna 6% and BioNTech picked up just under 5%.

PDS slipped 5% to lead on the downside.

 

Flat day to start the week. Tonix and Arcuturus fall 7%.

Very flat day with a loss of 0.2% overall. There were 14 gainers with 13 losers.

Tonix and Arcturus lead on the way down with losses just under 7%. On the plus side, BioNTech and Vir gained just over 6%.

 

Tough week for Novavax and rest of the TOP TEN - except Altimmune

Real Tough week for the TOP TEN. Only Altimmune picked up ground. Novavax's return falls 221% down to 990%. 

Total return falls back under 200% - down to 197%. 

 

Strong days for PDS, CureVac and Vir overwhelmed by overall sell-off. Flat day overall to finish the week

On a market sell-off day, Covid Vaccine Stocks were absolutely flat on average but with only eight gaining ground and 18 losing ground. 

Of all the losing stocks, none fell more than 5%. 

On the upside, PDS continued its yo-yo with an amazing 16% gain, while CureVac dead-cat bounced back 7% after falling off a cliff yesterday. The other winner today was Vir - up 5%. 

 

CureVac collapse - falls 39% - tarnishes otherwise positive day.

CureVac collapse....Falls 39% on poor clinical data. 

Seventeen stocks did gain ground and nine lost ground for an overall average loss of 0.5%. Without the Curevac pummeling, it would have been a positive day overall.

Translate Bio fell over 8%, while PDS picked up more than 6%. BioNTech and Adaptive picked up 5%.

 

Altimmune shines on tough day

 

Another tough day for COVID VACCINE STOCKS with one exception. Altimmune climbed 16.5% on some non-covid vaccine clinical results.

Two of three stocks lost ground and the overall average was a loss of 0.8%.

Leading on the downside, was Tonix which fell 7.5%, then BioNTech, Generex and Novavax which fell 6%.

 

Terrible Blood bath - PDS falls 28%, Vaxart 11% and Novavax 10%. Every stock falls.

A promising day turns into an absolute disaster. A sell fest like none other. Every single stock got blasted. A unanimous blood bath.

The overall average was a loss of 4.6%. 

PDS Bio got crunched, falling over 28%. Vaxart tanked just under 11% while Novavax lost 10%. Onco Sec slipped a full 8% and several stocks lost in the 5, 6 or 7% range.

The top performer was Alnylam which only lost 0.1%. 

 

Sorrento and PDS put in strong days while BioNTech and Moderna fall on flat day overall

Quite a flat day overall with the average gain at 0.3% even though 13 stocks fell and 12 gained ground. 

The top two stocks were Sorrento and PDS Bio gaining just under 7%. VBI also gained 6% while GeoVax picked up just under 5%.

BioNTech slipped 7.5% and Moderna slipped 5% to lead on the downside. There were no double digit movers today.

 

Steady growth in BOTTOM TEN - Tonix and Gritstone move up 2 spots.

Positive moves in the BOTTOM TEN with Alnyam and Tonix both picking up their returns 16%. IMV and EBS stumbled more falling 12% and 6% respectively.

Tonix and Gritstone both jumped two spots.

 

Novavax rockets back up to top - total return up to 221%

Novavax absolutely rocks back to top spot, upping its total return from 1044% to 1211%. In four weeks, it has moved the return from 731% back up almost 500 points. 

PDS Bio dropped its return a full 59%. Immunity Bio was the only other top ten stock to drop - Immunity lost 48% on its total return, falling all the way from sixth down to tenth.

The total return has climbed up to 221% - getting closer to the maximum highest return of 280% reached on February 13.

 

Vaxart - way up, Heat Bio way down. Flat overall.

Two stocks with yo-yo weeks made big moves in opposite directions. Vaxart jumped up just 22% while Heat Biologics gave pack half of the enormous gain last week, fall over 20%. 

NanoViricides had a strong double day, gaining over 11%. Generex also bounced back after recent weakness, with a gain of over 5%. 

CureVac stumbled below $100, falling over 7%. 

Overall, stocks gained 0.4% on average with 14 stocks gaining and 13 losing ground.

 

Heat Biologics climbs 40% on cancer data

Heat Biologics blows up on positive cancer therapy data. Thirteen stocks gained ground with 12 losing and two flat. Thanks to the out-sized gain by Heat Biologics, the overall average was a gain of 1.6%.

IBio and Adaptive picked up 6% while VBI picked up 5%.

On the downside, Inovio fell 8%, Altimmune fell 7% and Vaxart fell 6%.

 

Inovio up 17% on another positive day overall

Strong up day again. Two thirds of stocks moved up and one third down. The overall average was a gain of 2.3%.

Inovio moved up the most with a 17% gain. BioNTech built on recent strength with another huge move - this time up just under 10%. Altimmune gained 9%.

Translate Bio gained 7% while PDS Bio picked up another 6%. Novavax and Arcturus picked up around 5%. 

On the downside Generex fell just under 5% to lead on the downside.

 

PDS Bio back to the win column, VBI makes double digit gain - CureVac whacked.

A down day flips around in the afternoon for most stocks. Sixteen stocks were up with 11 losing ground. The stocks managed an overall gain of 1.1%.

PDS Bio bounced back big time with a gain of just under 19%. VBI, which has tailed back is beginning so show some strength. It gained over 14% today.  Other strong stocks today included:  Translate Bio, iBio and Gritstone with gains in the 6% range.

CureVac got whacked with a report of delays in approvals, today falling back over 12%.  BioNTech had a rare bad day, falling over 7%. Adaptive fell in the 6% range.

 

PDS and Immunity Bio crater on a strong up day

Wild Day! Fully 24 stocks made gains today with only three losing ground. The overall average was a gain of 2.5%. However, those three got hit hard: PDS Bio returned a full 26% after an amazing run. Immunity Bio dropped 12% and Generex fell 4.4%. Without these losers, the overall gain would have been 4.1%.

Strong gains were broad-based, but there were no double digit gains. CureVax gained just under 8%, Arcturus, Vaxart, Novavax and Moderna all gained around 7%. Inovio, Heat Biologics, Vir all gained around 6% while VBI, Onco Sec, NanoViricides, Tonix and Adaptive all gained 5%.

 

Emergent Bio and IMV move up 11%

IMV and Emergent Bio have decent weeks, moving their overall return up 11% this week. 

 

Novavax back as King, bumping out PDS Bio - Overall returns back over 200%

Novavax re-asserts its dominance, bumping out PDS Bio. The overall average for all stocks climbed up 19% to climb back up to 202% overall.

Novavax rocked forward, moving its return up a full 219% up to 1044%. Both Moderna and BioNTech also had very strong weeks up 84% and 82% respectively.

VBI backed into TOP TEN for the first time in awhile with the fall of Onco Sec.

 

PDS Bio finishes week with another out-sized gain. Big Boys very strong (BioNTech, Moderna and Novavax)

Stocks close out the week with a gain of 1.0% on average. Fifteen stocks gained ground and 12 lost. 

The biggest winner was again PDS Bio with another double digit gain of 13%. After that, the big boys gained further ground with BioNTech gaining 8%, Moderna 6% and Novavax 5%.

Onco Sec stumbled 5% to lead the way on the downside.

 

Relatively flat day - VBI falls just under 6%.

Covid Vaccine stocks sag somewhat with 16 stocks slipping and nine gaining ground. The overall average was a loss of 0.8%.

The only stock moving more than 5% was VBI which fell 5.7%.

 

Novavax roars back with a gain of 18%, Vaxart and Sorrento make big move.

The King Returns - Novavax soars 18%! Vaxart runs up 12% and Sorrento breaks out over 10%. 

There were 19 winners and 7 losers. The overall average was a very strong gain of 3.3%.

Other strong performers were Inovio and Vir at 7%. BioNTech, VBI and Cure Vac all gained 6%. Finally, Altimmune gained over 5%.

The only loser that fell beyond 5% is Onco Sec.

 

PDS Bio finally stumbles, falling 11% - stocks down 0.4% on average. Tonix top performer

An up and down day ended pretty level today with 14 stocks losing ground and 12 gaining. The biggest loser was PDS Bio, which finally faced some selling after an amazing run; falling 11%. 

The overall average was a loss of 0.4%.

GeoVax stumbled just over 5% while Tonix was the top performer, gaining 5%.